BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 6450653)

  • 1. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
    Nies KM; Stevens RH; Louie JS
    J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.
    Smith G; Morrison CA; Maddison PJ
    Clin Exp Immunol; 1987 Jun; 68(3):552-61. PubMed ID: 2958189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
    Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
    J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation of immunoglobulin production in normal infants and children.
    Nouri-Aria KT; Lobo-Yeo A; Vergani D; Mieli-Vergani G; Mowat AP; Eddleston AL
    Clin Exp Immunol; 1985 Mar; 59(3):679-86. PubMed ID: 3157518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin production in human mixed lymphocyte cultures: implications for co-cultures of cells from patients and healthy donors.
    Rümke HC; Terpstra FG; Huis B; Out TA; Zeijlemaker WP
    J Immunol; 1982 Feb; 128(2):696-701. PubMed ID: 6459383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of polyclonal immunoglobulin biosynthesis by a soluble factor: T-cell dependent and T-cell independent mitogens.
    Krakauer RS; Cathcart MK; Ilfeld DN
    Immunology; 1980 May; 40(1):53-60. PubMed ID: 6448220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.
    Rümke HC; Terpstra FG; Roos MT; Vossen JM; Dooren LJ; Schellekens PT; Zeijlemaker WP
    Clin Exp Immunol; 1984 Aug; 57(2):467-78. PubMed ID: 6235992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.
    Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
    Clin Exp Immunol; 1984 Aug; 57(2):338-44. PubMed ID: 6331922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
    Sagawa A; Abdou NI
    J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.
    Ginsburg WW; Finkelman FD; Lipsky PE
    Clin Exp Immunol; 1979 Jan; 35(1):76-88. PubMed ID: 154983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental changes in humoral suppressor activity released from concanavalin A-stimulated human lymphocytes on B cell differentiation.
    Miyawaki T; Kubo M; Nagaoki T; Moriya N; Yokoi T; Mukai M; Taniguchi N
    J Immunol; 1981 May; 126(5):1720-3. PubMed ID: 6452476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.